STOCK TITAN

SOPHiA GENETICS to Report Third Quarter 2021 Financial Results on November 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) announced it will report Q3 financial results on November 10, 2021, before the market opens. Management will host a webcast at 8:30 a.m. ET to discuss results, business advancements, and future outlook. The SOPHiA DDM™ Platform, their cloud-based SaaS solution, is utilized by over 780 institutions globally, aiming to set data-driven medicine as a standard. The live audio will be available on the company’s Investors section of the website, with an archived replay afterwards.

Positive
  • SOPHiA DDM™ Platform used by over 780 institutions worldwide.
Negative
  • None.

BOSTON and LAUSANNE, Switzerland, Oct. 27, 2021 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH) today announced it will report financial results for the third quarter of 2021 before market open on Wednesday, November 10, 2021. The company’s management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 2:30 p.m. Central European Time to discuss its results, business developments, and outlook.

Live audio of the webcast will be available on the “Investors” section of the company website at ir.sophiagenetics.com. An archived replay will be available on the company’s website following the event.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory, and biopharma institutions globally.

Media Contact:
Eliza Bamonti
ebamonti@sophiagenetics.com

Investor Contact:
ir@sophiagenetics.com


FAQ

What date will SOPHiA GENETICS report its Q3 2021 financial results?

SOPHiA GENETICS will report its Q3 2021 financial results on November 10, 2021.

What time is the SOPHiA GENETICS Q3 2021 results conference call?

The conference call for SOPHiA GENETICS Q3 2021 results will begin at 8:30 a.m. ET.

Where can I listen to SOPHiA GENETICS' conference call?

You can listen to the conference call on the Investors section of the SOPHiA GENETICS website.

What is the main focus of SOPHiA GENETICS?

SOPHiA GENETICS focuses on data-driven medicine through its SOPHiA DDM™ Platform.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

241.89M
65.38M
5.84%
49.85%
0.02%
Health Information Services
Healthcare
Link
United States of America
Rolle